The DOI matches its Crossref record; 62 of the 63 references it cites were found in a registry or an index.
The Proinflammatory Cytokines Interleukin-1beta and Tumor Necrosis Factor-Alpha Activate Serotonin Transporters
Abstract
Proinflammatory cytokines and serotonergic homeostasis have both been implicated in the pathophysiology of major psychiatric disorders. We have demonstrated that activation of p38 mitogen-activated protein kinase (MAPK) induces a catalytic activation of the serotonin transporter (SERT) arising from a reduction in the SERT Km for 5-hydroxytryptamine (5-HT). As inflammatory cytokines can activate p38 MAPK, we hypothesized that they might also activate neuronal SERT. Indeed, Interleukin-1beta (IL-1beta) and tumor necrosis factor alpha (TNF-alpha) stimulated serotonin uptake in both the rat embryonic raphe cell line, RN46A, and in mouse midbrain and striatal synaptosomes. In RN46A cells, IL-1beta stimulated 5-HT uptake in a dose- and time-dependent manner, peaking in 20 min at 100 ng/ml. This was abolished by IL-1ra (20 ng/ml), an antagonist of the IL-1 receptor, and by SB203580 (5 microM), a p38 MAPK inhibitor. TNF-alpha also dose- and time-dependently stimulated 5-HT uptake that was only partially blocked by SB203580. Western blots showed that IL-1beta and TNF-alpha activated p38 MAPK, in an SB203580-sensitive manner. IL-1beta induced an SB203580-sensitive decrease in 5-HT Km with no significant change in Vmax. In contrast, TNF-alpha stimulation decreased 5-HT Km and increased SERT Vmax. SB203580 selectively blocked the TNF-alpha-induced change in SERT Km. In mouse midbrain and striatal synaptosomes, maximal stimulatory effects on 5-HT uptake occurred at lower concentrations (IL-1beta, 10 ng/ml; TNF-alpha, 20 ng/ml), and over shorter incubation times (10 min). As with RN46A cells, the effects of IL-1beta and TNF-alpha were completely (IL-1beta) or partially (TNF-alpha) blocked by SB203580. These results provide the first evidence that proinflammatory cytokines can acutely regulate neuronal SERT activity via p38 MAPK-linked pathways.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Interestingly, inflammatory cytokines, including IL-6, have been shown to increase 5-HTT expression and function (Morikawa et al., 1998, Mossner et al., 1998, Sakai et al., 2003, Tsao et al., 2008) (see Figure 1), an effect found to be mediated by induction of p38 mitogen-activated protein kinase (MAPK), both in vitro and in vivo (Zhu et al., 2005, Zhu et al., 2006, Zhu et al., 2010a).”
From Inflammatory cytokines in depression: neurobiological mechanisms and therapeutic implications (2013) · cites this paper as Zhu et al., 2006
In the citing paper
“Cytokines also influence the synthesis of monoamines through disruption of tetrahydrobiopterin, an essential enzyme co-factor to hydroxylases involved in monoamine synthesis.”
From Cytokine Research in Depression: Principles, Challenges, and Open Questions (2019) · cites this paper as [89]
In the citing paper
“Furthermore, they can modulate serotonin signaling by increasing the expression and function of monoamine transporters which perform the re-uptake of synaptic serotonin (89–92).”
From Cytokine Research in Depression: Principles, Challenges, and Open Questions (2019) · cites this paper as [89]
Citations
Cites
Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene
Caspi, A., Sugden, K., Moffitt, T. E., Taylor, A., Craig, I. W., Harrington, H., McClay, J., Mill, J., Martin, J., Braithwaite, A., et al. (2003) · Science · doi:10.1126/science.1083968 · Cited by 8,120
Psychopharmacology: The Fourth Generation of Progress
Bloom, F. E., & Kupfer, D. J. (1995) · Medical Entomology and Zoology · Cited by 2,985
Cytokines and major depression
Schiepers, O. J. G., Wichers, M. C., & Maes, M. (2005) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2004.11.003 · Cited by 1,235
Differential Regulation of AMPA Receptor and GABA Receptor Trafficking by Tumor Necrosis Factor-α
Stellwagen, D., Beattie, E. C., Seo, J. Y., & Malenka, R. C. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.4486-04.2005 · Cited by 985 · cited 1×
“Similarly, short-term exposure of hippocampal neurons to TNF-a (15–30 min) has been found to induce endocytosis of GABA-A receptors and increase trafficking of excitatory AMPA receptors to the plasma membrane (Stellwagen et al, 2005).”
BackgroundcDNA Expression Cloning of the IL-1 Receptor, a Member of the Immunoglobulin Superfamily
Sims, J. E., March, C. J., Cosman, D. J., Widmer, M. B., MacDonald, H. R., McMahan, C. J., Grubin, C. E., Wignall, J. M., Jackson, J. L., Call, S. M., et al. (1988) · Science · doi:10.1126/science.2969618 · Cited by 877
Cytokine‐Induced Sickness Behavior: Mechanisms and Implications
Dantzer, R. (2001) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2001.tb05827.x · Cited by 825
Psychopharmacology: The Fourth Generation of Progress
Kramlinger, K. G. (1995) · Mayo Clinic Proceedings · doi:10.4065/70.10.1021-a · Cited by 779
Interleukin-1 Immunoreactive Innervation of the Human Hypothalamus
Breder, C. D., Dinarello, C. A., & Saper, C. B. (1988) · Science · doi:10.1126/science.3258444 · Cited by 755
Brockhaus, M., Schönfeld, H., Schlaeǵer, E.-J., Hunziker, W. H., Lesslauer, W., & Loetscher, H. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.8.3127 · Cited by 649
Li, Y.-P., Chen, Y., John, J., Moylan, J. S., Jin, B., Mann, D. L., & Reid, M. B. (2005) · The FASEB Journal · doi:10.1096/fj.04-2364com · Cited by 634
Cited by
Sorted by citations
Items 301–400 of 547
Shukkoor, M. S. A., Baharuldin, M. T. H., Jais, A. M. M., Moklas, M. A. M., & Fakurazi, S. (2016) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2016/2986090 · Cited by 26
Socio-demographic, Clinical, and Genetic Determinants of Quality of Life in Lung Cancer Patients
Pierzynski, J. A., Ye, Y., Lippman, S. M., Rodriguez, M. A., Wu, X., & Hildebrandt, M. A. T. (2018) · Scientific Reports · doi:10.1038/s41598-018-25712-1 · Cited by 27
Wang, Q., Zeng, L., Hong, W., Luo, M., Zhao, N., Hu, X., Shi, M., Qiu, J., Shen, Y., Teng, X., et al. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.925007 · Cited by 22
Kébir, O., Gorsane, M.-A., Blecha, L., Krebs, M., Reynaud, M., & Benyamina, A. (2011) · European Addiction Research · doi:10.1159/000324849 · Cited by 23
Korte-Bouws, G. A. H., van Heesch, F., Westphal, K. G. C., Ankersmit, L. M. J., van Oosten, E., Güntürkün, O., & Korte, S. M. (2018) · Pharmaceuticals · doi:10.3390/ph11030066 · Cited by 24
Serotonin transporter regulation by cholesterol-independent lipid signaling
Deveau, C., Rodriguez, E., Schroering, A. G., & Yamamoto, B. K. (2020) · Biochemical Pharmacology · doi:10.1016/j.bcp.2020.114349 · Cited by 22
Immune System Contributions to the Pathophysiology of Depression
Miller, A. H., & Raison, C. L. (2008) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/foc.6.1.foc36 · Cited by 26
SSRIs: Applications in inflammatory lung disease and implications for COVID‐19
Meikle, C. K., Creeden, J. F., McCullumsmith, C. B., & Worth, R. G. (2021) · Neuropsychopharmacology Reports · doi:10.1002/npr2.12194 · Cited by 20
Nassar, A., Sharon-Granit, Y., & Azab, A. N. (2016) · Neuroscience Letters · doi:10.1016/j.neulet.2016.05.019 · Cited by 20
Gilbert, J., Haman, K., Dietrich, M. S., Blakely, R., Shelton, R. C., & Murphy, B. A. (2011) · Head & Neck · doi:10.1002/hed.21744 · Cited by 21
Self-citationThe Role of the Gut Microbiota and Microbial Metabolites in the Pathogenesis of Alzheimer’s Disease
Wang, Y. (2022) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527321666220417005115 · Cited by 21
Sánchez‐Carro, Y., de la Torre‐Luque, A., Leal‐Leturia, I., Salvat‐Pujol, N., Massaneda‐Tuneu, C., de Arriba‐Arnau, A., Urretavizcaya, M., Pérez, V., Toll, A., Martı́nez-Ruiz, A., et al. (2022) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2022.110674 · Cited by 25
Cytokine levels in CSF and neuropsychological performance in HIV patients
and the German Competence Network HIV/AIDS, Nolting, T., Lindecke, A., Hartung, H., Koutsilieri, E., Maschke, M., Husstedt, I., Sopper, S., Stüve, O., & Arendt, G. (2012) · Journal of NeuroVirology · doi:10.1007/s13365-012-0091-4 · Cited by 20
Depressive-like behaviour induced by an intracerebroventricular injection of streptozotocin in mice
Souza, L. C., Filho, C. B., Fabbro, L. D., de Gomes, M. G., Goes, A. T. R., & Jessé, C. R. (2013) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e32835efc2f · Cited by 20
Sáiz, P. A., García‐Portilla, M. P., Flórez, G., Corcoran, P. E., Arango, C., Morales, B., Leza, J. C., Álvarez, S., Mesa, E. M. D., Álvarez, V., et al. (2009) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2009.01058.x · Cited by 20
Schwamborn, R., Brown, E., & Haase, J. K. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13596 · Cited by 20
Effects of prenatal opioid and alcohol exposures on immune and serotonin factors in human placenta
Ruyak, S. L., Noor, S., DiDomenico, J., Sun, M. S., Fernandez-Oropeza, A. K., Rodriguez, D. E., Marquez, L. E., Milligan, E. D., & Bakhireva, L. N. (2022) · Experimental Neurology · doi:10.1016/j.expneurol.2022.114057 · Cited by 18
Цейликман, В. Э., Tseilikman, O. B., Yegorov, O. N., Brichagina, A. A., Karpenko, M. N., Tseilikman, D., Shatilov, V. A., Zhukov, M. S., & Novak, J. (2024) · Nutrients · doi:10.3390/nu16172856 · Cited by 19
Brown, E., Veigh, C. J. M., Santos, L. L., Gogarty, M., Müller, H. K., Elfving, B., Brayden, D. J., & Haase, J. K. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2018.04.023 · Cited by 19
Liu, K., Zhao, X., Lu, X., Zhu, X., Chen, H., Wang, M., Yan, W., Jing, L., Deng, Y., Yu, L., et al. (2018) · Psychological Medicine · doi:10.1017/s0033291718003616 · Cited by 18
Brás, J. P., Pinto, S. F. T., Almeida, M. I., Prata, J., von Doellinger, O., Coelho, R. C., Barbosa, M. A., & Santos, S. G. (2019) · Methods in molecular biology · doi:10.1007/978-1-4939-9554-7_28 · Cited by 19
Gestational Age Variation in Human Placental Drug Transporters
Goetzl, L. M., Darbinian, N., Merabova, N., DeVane, L., & Ramamoorthy, S. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.837694 · Cited by 18
Neuro-immune crosstalk in depressive symptoms of multiple sclerosis
Wang, C., Zhou, Y., & Feinstein, A. (2023) · Neurobiology of Disease · doi:10.1016/j.nbd.2023.106005 · Cited by 20
Serotonin is a common thread linking different classes of antidepressants
Witt, C. E., Mena, S., Holmes, J., Hersey, M., Buchanan, A. M., Parke, B., Saylor, R., Honan, L. E., Berger, S. N., Lumbreras, S., et al. (2023) · Cell Chemical Biology · doi:10.1016/j.chembiol.2023.10.009 · Cited by 18
Mohammad, T. A. M., Mohammad, T. A. M., Salman, D. M., & Jaafar, H. M. (2024) · Pharmacopsychiatry · doi:10.1055/a-2291-7204 · Cited by 19
Lee, S.-Y., Wang, T., Chen, S., Chang, Y., Chen, P. S., Huang, S., Tzeng, N., Wang, L., Lee, I., Chen, K.-C., et al. (2020) · International Journal of Bipolar Disorders · doi:10.1186/s40345-019-0174-8 · Cited by 19
Neuroimmunological effects of early life experiences
Brydges, N. M., & Reddaway, J. (2020) · Brain and Neuroscience Advances · doi:10.1177/2398212820953706 · Cited by 20
Early warning biomarkers in major depressive disorder: a strategic approach to a testing question
Pratt, R., & Stapelberg, N. J. C. (2018) · Biomarkers · doi:10.1080/1354750x.2018.1463563 · Cited by 17
Varman, D. R., Jayanthi, L. D., & Ramamoorthy, S. (2020) · Journal of Neurochemistry · doi:10.1111/jnc.15152 · Cited by 17
In Silico Study Examining New Phenylpropanoids Targets with Antidepressant Activity
Calixto, P. D. S., de Almeida, R. N., Salvadori, M. G. D. S. S., Maia, M. D. S., Barbosa‐Filho, J. M., Scotti, L., & Scotti, L. (2020) · Current Drug Targets · doi:10.2174/1389450121666200902171838 · Cited by 18
The Metallome as a Link Between the “Omes” in Autism Spectrum Disorders
Stanton, J. E., Malijauskaite, S., McGourty, K., & Grabrucker, A. M. (2021) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2021.695873 · Cited by 16
Immune and neuroendocrine correlates of temperament in infancy
O’Connor, T. G., Scheible, K. M., Sefair, A. V., Gilchrist, M., Blackmore, E. R., Winter, M. A., Gunnar, M. R., Wyman, C. P., Carnahan, J. A., Moynihan, J. A., et al. (2017) · Development and Psychopathology · doi:10.1017/s0954579417001250 · Cited by 19
Nayem, J., Sarker, R., Roknuzzaman, A. S. M., Qusar, M. S., Raihan, S. Z., Islam, M. R., & Mahmud, Z. A. (2023) · PLoS ONE · doi:10.1371/journal.pone.0294288 · Cited by 18
Qi, J., Jin, Y., Wang, X., Yang, L.-K., Lu, L., Yue, J., Yang, F., Liu, Y., Jiang, Y., Song, D., et al. (2024) · Phytotherapy Research · doi:10.1002/ptr.8325 · Cited by 16
Positron Emission Tomography Molecular Imaging in Late-Life Depression
Hirao, K., & Smith, G. S. (2014) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/0891988713516540 · Cited by 15
Wróbel, A., Serefko, A., Woźniak, A., Kociszewski, J., Szopa, A., Wiśniewski, R., & Poleszak, E. (2019) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2019.172842 · Cited by 17
Shi, Y., Yang, H., He, C., Wang, Y., Zheng, J., Wang, X., Hao, F., Feng, C., Ma, L., Zhang, Y., et al. (2025) · Frontiers in Neuroscience · doi:10.3389/fnins.2025.1614297 · Cited by 18
Shvartsur, R., Agam, G., Uzzan, S., & Azab, A. N. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14050901 · Cited by 16
Lin, S., Chen, Z., Wu, Z., Fei, F., Xu, Z., Tong, Y., Sun, W., & Wang, P. (2023) · Neurochemical Research · doi:10.1007/s11064-023-04051-2 · Cited by 16
Andreetta, F., Barnes, N. M., Wren, P. B., & Carboni, L. (2013) · Life Sciences · doi:10.1016/j.lfs.2013.05.014 · Cited by 14
Is the Exposome Involved in Brain Disorders through the Serotoninergic System?
Sarrouilhe, D., Defamie, N., & Mesnil, M. (2021) · Biomedicines · doi:10.3390/biomedicines9101351 · Cited by 17
Yang, Y., Hu, R., Zheng, J., Wang, Q., Xu, S., Zhou, Z., Zhang, D., & Shen, W. (2023) · Journal of Nanobiotechnology · doi:10.1186/s12951-023-01893-4 · Cited by 14
Sáiz, P. A., García‐Portilla, M. P., Paredes, B., Arango, C., Morales, B., Álvarez, V., Coto, E., Bobes-Bascarán, T., Bousoño, M., & Bobes, J. (2008) · Psychiatric Genetics · doi:10.1097/ypg.0b013e3282fb002a · Cited by 14
Krout, D., Rodriquez, M., Brose, S. A., Golovko, M. Y., Henry, L. K., & Thompson, B. J. (2016) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.6b00343 · Cited by 14
Reddaway, J., & Brydges, N. M. (2020) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2020.103567 · Cited by 17
van, D. K. P., Mühlbauer, E., & Phi‐van, L. (2015) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2015.05.008 · Cited by 14
Gene expression in lungs of mice lacking the 5-hydroxytryptamine transporter gene
Crona, D. J., Harral, J. W., Adnot, S., Eddahibi, S., & West, J. D. (2009) · BMC Pulmonary Medicine · doi:10.1186/1471-2466-9-19 · Cited by 14
Cancer Fatigue: A Neurobiological Review for Psychiatrists
Levy, M. R. (2008) · Psychosomatics · doi:10.1176/appi.psy.49.4.283 · Cited by 13
Rousseau, S. (2011) · AfCS-Nature Molecule Pages · doi:10.1038/mp.a001717.01 · Cited by 13
The core inflammatory factors in patients with major depressive disorder: a network analysis
Zeng, Y., Sun, B., Zhang, F., Hu, Z., Li, W., Lan, X., Ning, Y., & Zhou, Y. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1216583 · Cited by 15
On Redefining the Role of the Immune System in Psychiatric Disease
Miller, A. H., & Manji, H. K. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.09.013 · Cited by 13
Castro, M. A. D., Garofalo, S., Mormino, A., Carbonari, L., Pietro, E. D., Felice, E. D., Catalano, M., Maggi, L., & Limatola, C. (2023) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2023.11.015 · Cited by 14
Inflammatory Biomarkers, Microbiome, Depression, and Executive Dysfunction in Alcohol Users
Rodríguez-Rabassa, M., López, P. L., Sánchez, R., Hernández, C., Rodríguez, C., Rodríguez-Santiago, R. E., Orengo, J. C., Green, V., Yamamura, Y., & Rivera‐Amill, V. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17030689 · Cited by 15
RETRACTED: Exploring the role of biologics in depression
Rani, T., Behl, T., Sharma, N., Makeen, H. A., Albratty, M., Alhazmi, H. A., Meraya, A. M., Bhatia, S., & BUNGAU, S. G. (2022) · Cellular Signalling · doi:10.1016/j.cellsig.2022.110409 · Cited by 12
RetractedCho, H., Jo, M., Oh, H., Lee, Y., & Park, Y. (2023) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2023.109326 · Cited by 11
Whale, R., Fialho, R., Rolt, M., Eccles, J., Pereira, M., Keller, M., File, A., Haq, I., & Tibble, J. A. (2015) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2015.06.003 · Cited by 12
La inflamación y sus desencantos: papel de las citocinas en la fisiopatología de la depresión mayor
Miller, A. H., Maletic, V., & Raison, C. L. (2010) · Psiquiatría Biológica · doi:10.1016/j.psiq.2010.04.001 · Cited by 16
Tagging SNP association study of the IL‐1β gene (IL1B) and childhood‐onset mood disorders
Misener, V. L., Gomez, L., Wigg, K. G., King, N. A., Kiss, E., Daróczi, G., Kapornai, K., Tamás, Z., Mayer, L., Gádoros, J., et al. (2008) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30885 · Cited by 12
Mohamed, S. S., Rasheed, N. O. A., Ibrahim, W. W., & Shiha, N. A. (2024) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-024-10149-3 · Cited by 11
El‐Bakly, W. M., & Hasanin, A. H. (2014) · Korean Journal of Physiology and Pharmacology · doi:10.4196/kjpp.2014.18.3.233 · Cited by 11
Stilley, S. E., & Blakely, R. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.677563 · Cited by 13
Self-citationPolyphenols as possible alternative agents in chronic fatigue: a review
Ullah, H., Khan, A., Riccioni, C. V., Minno, A. D., Tantipongpiradet, A., Buccato, D. G., Lellis, L. F. D., Khan, H. Z., Xiao, J., & Daglia, M. (2022) · Phytochemistry Reviews · doi:10.1007/s11101-022-09838-9 · Cited by 12
University of Veterinary Medicine Hannover
Komm, K. (2010) · Cited by 11
Modulation of serotonin transporter expression by escitalopram under inflammation
Mena, S., Cruikshank, A., Best, J. A., Nijhout, H. F., Reed, M. C., & Hashemi, P. (2024) · Communications Biology · doi:10.1038/s42003-024-06240-3 · Cited by 11
Phosphodiesterase 4 Inhibition in Neuropsychiatric Disorders Associated with Alzheimer’s Disease
Chen, J., Zhu, Z., Xu, F., Dou, B., Sheng, Z., & Xu, Y. (2025) · Cells · doi:10.3390/cells14030164 · Cited by 10
Barzilay, R., Ventorp, F., Segal‐Gavish, H., Aharony, I., Bieber, A., Dar, S., Vescan, M., Globus, R., Weizman, A., Naor, D., et al. (2016) · Journal of Molecular Neuroscience · doi:10.1007/s12031-016-0835-3 · Cited by 10
Ribeiro, A. B., de Barcellos-Filho, P. C. G., Franci, C. R., Menescal-de-Oliveira, L., & Saia, R. (2016) · Acta Physiologica · doi:10.1111/apha.12729 · Cited by 11
Inflammatory illness: Why the next wave of antidepressants may target the immune system
Wetsman, N. (2017) · Nature Medicine · doi:10.1038/nm0917-1009 · Cited by 10
The Neurochemistry of Depression: The Good, The Bad and The Ugly.
Pearson, K., Beier, K., Mardis, T., Munoz, B., & Zaidi, A. (2024) · PubMed Central · Cited by 10
Sarmin, N., Roknuzzaman, A. S. M., Sarker, R., Mamun-or-Rashid, Hasan, A., Qusar, M. S., Kabir, E. R., Islam, M. R., & Mahmud, Z. A. (2024) · PLoS ONE · doi:10.1371/journal.pone.0306125 · Cited by 10
Patterson, B. K., Guevara-Coto, J. A., Mora, J., Francisco, E. B., Yogendra, R., Mora-Rodríguez, R. A., Beaty, C., Lemaster, G., Gary Kaplan, D. O., Katz, A., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-70929-y · Cited by 11
Molecular mechanisms and clinical value of the correlation between depression and cancer
Chen, Y., Lu, Y.-F., Chen, S., Liu, P., He, J., Jiang, L., & Zhang, J. (2025) · Medical Oncology · doi:10.1007/s12032-025-02763-9 · Cited by 10
Stapelberg, N. J. C., Bui, T. A., Mansour, V., Johnson, S., Branjerdporn, G., Adhikary, S. R., Ashton, K. J., Taylor, N., & Headrick, J. P. (2022) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2022.577959 · Cited by 9
Anti-Inflammatory Therapy as a Promising Target in Neuropsychiatric Disorders
Ballaz, S., & Bourin, M. (2023) · Advances in experimental medicine and biology · doi:10.1007/978-981-19-7376-5_20 · Cited by 10
Elgendi, A. M., Nada, H., Mosbeh, A. S., Maatouk, M. A., Abulghany, M., & Gulliver, W. P. F. (2015) · Journal of Dermatology & Dermatologic Surgery · doi:10.1016/j.jdds.2014.03.005 · Cited by 9
Inhibition of serotonin transporter expression by C/EBPβ in LPS-activated macrophage cells (HD11)
Zimmermann, K., Van, V. D. P., Brase, A., & Phi‐van, L. (2014) · Innate Immunity · doi:10.1177/1753425914547434 · Cited by 9
Fujikawa, R., Higuchi, S., Nakatsuji, M., Yasui, M., Ikedo, T., Nagata, M., Hayashi, K., Yokode, M., & Minami, M. (2017) · American Journal Of Pathology · doi:10.1016/j.ajpath.2017.04.010 · Cited by 9
El‐Sisi, A. E., Sokar, S. S., Shalaby, M. F., & Abu-Risha, S. E.-S. (2021) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2021.1933435 · Cited by 9
Demir, E. A., Duran, G. G., Küçük, M. U., Doğan, H. D., Tutuk, O., Açıkgül, F. Ç., Bayırlı, M., Tümer, C., & Duran, N. (2022) · Molecular Neurobiology · doi:10.1007/s12035-022-02831-5 · Cited by 8
Yu, L., An, C., Jia, L., Li, Y., Chen, Q., Zhen, F., Wang, S., & Wang, M. (2015) · World Neurosurgery · doi:10.1016/j.wneu.2015.09.071 · Cited by 9
The Future of Psychoneuroimmunology: Promises and Challenges
Halaris, A. E., Bechter, K., Haroon, E., Leonard, B. E., Miller, A. H., Pariante, C. M., & Zunszain, P. A. (2018) · Springer eBooks · doi:10.1007/978-3-319-70554-5_15 · Cited by 9
Persico, A. M. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-397267-5.00045-5 · Cited by 9
Psychoneuroimmunology and multiple sclerosis
Melnikov, M., Pashchekov, М. V., & Boyко, A. (2015) · S S Korsakov Journal of Neurology and Psychiatry · doi:10.17116/jnevro2015115228-15 · Cited by 8
Inflammation as a mediator of stress-related psychiatric disorders
Flux, M. C., & Lowry, C. A. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-85654-6.00052-6 · Cited by 10
Avula, S. K., Khan, A., Halim, S. A., Rehman, N. U., Karim, N., Khan, I., Csük, R., Das, B., & Al‐Harrasi, A. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113960 · Cited by 7
RetractedMarcinkowska, M., Mordyl, B., Siwek, A., Głuch‐Lutwin, M., Karcz, T. P., Gawalska, A., Sapa, M., Bucki, A., Szafrańska, K., Pomierny, B., et al. (2023) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.3c00033 · Cited by 8
Gonda, X., Serafini, G., & Döme, P. (2023) · Journal of Personalized Medicine · doi:10.3390/jpm13071078 · Cited by 9
Gajewski-Kurdziel, P. A., Walsh, A. E., & Blakely, R. (2024) · Current Research in Physiology · doi:10.1016/j.crphys.2024.100117 · Cited by 8
Self-citationChoi, W., Kang, H., Kim, J., Kim, H. K., Kang, H., Lee, J., Kim, S., Stewart, R. J., & Kim, J. (2021) · Translational Psychiatry · doi:10.1038/s41398-021-01581-7 · Cited by 9
Depression in patients with ankylosing spondylitis
Ma, T., Geng, Y., & Li, P. (2022) · Rheumatology & autoimmunity · doi:10.1002/rai2.12020 · Cited by 7
Moreira, L. K. D. S., Turones, L. C., Campos, H. M., Martins, A. N., Thomaz, D. V., Gil, E. D. S., Ghedini, P. C., da Rocha, F. F., Menegatti, R., Fajemiroye, J. O., et al. (2022) · Life Sciences · doi:10.1016/j.lfs.2022.121199 · Cited by 9
Inflammation in Suicidality: Implications for Novel Treatment Options
Janelidze, S., & Brundin, L. (2013) · Modern trends in psychiatry · doi:10.1159/000346085 · Cited by 8
Suicidal Behavior: A Distinct Psychobiology?
Salloum, N. C. (2017) · American Journal of Psychiatry Residents Journal · doi:10.1176/appi.ajp-rj.2017.120101 · Cited by 8
Muñoz, J. L. P., Ocampos, D., Poblete‐Morales, M., Oyarzún, R., Morera, F. J., Tapia‐Cammas, D., Avendaño-Herrera, R. E., & Vargas‐Chacoff, L. (2019) · Comparative Biochemistry and Physiology Part A Molecular & Integrative Physiology · doi:10.1016/j.cbpa.2019.110525 · Cited by 8
Lin, H., Lin, W., Lin, F., Liu, C.-Y., Che, C., & Huang, H. (2022) · Computational Intelligence and Neuroscience · doi:10.1155/2022/6799285 · Cited by 7
RetractedGlycosylation changes of vWF in circulating extracellular vesicles to predict depression
Yamada, N., Tominaga, K., Tominaga, N., Kobayashi, A., Niino, C., Miyagi, Y., Yamagata, H., & Nakagawa, S. (2024) · Scientific Reports · doi:10.1038/s41598-024-80507-x · Cited by 7
Tanaka, M., Anders, S. L., & Kinney, D. K. (2012) · Molecular and integrative toxicology · doi:10.1007/978-1-61779-812-2_14 · Cited by 7
Wixey, J. A., Reinebrant, H. E., & Buller, K. M. (2012) · Neuroscience Research · doi:10.1016/j.neures.2012.04.002 · Cited by 7
Zhao, R., Wang, S., Huang, Z., Zhang, L., Yang, X., Bai, X., Zhou, D., Qin, Z., & Du, G. (2015) · BioScience Trends · doi:10.5582/bst.2015.01168 · Cited by 7
Fialho, R., Burridge, A., Pereira, M., Keller, M., File, A., Tibble, J. A., & Whale, R. (2015) · Psychopharmacology · doi:10.1007/s00213-015-3956-4 · Cited by 7
Metadata
- Authors
- Zhu, C.-B., Blakely, R. D., & Hewlett, W. A.
- Affiliations
- Vanderbilt University (US)
- Corresponding author
- Hewlett, William A
- Venue
- Neuropsychopharmacology
- Published
- 2006-02-01
- Volume
- 31
- Issue
- 10
- Pages
- 2121-2131
- ISSN
- 0893-133X (ISSN-L)
- 1740-634X
- OpenAlex
- W2065313926
- Cited by
- 549
- References
- 63
- Citations by year
- 2026: 14 · 2025: 19 · 2024: 21 · 2023: 32 · 2022: 32 · 2021: 34 · 2020: 30 · 2019: 31 · 2018: 28 · 2017: 21 · 2016: 33 · 2015: 38 · 2014: 38 · 2013: 40 · 2012: 37
- FWCI
- 5.81
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Neuropsychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Alliance for Research on Schizophrenia and Depression
- National Institute on Drug Abuse (DA-07390, R01DA007390)
- Topics
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Keywords
- serotonin transporter, IL-1β, TNF-α, inflammatory cytokines, p38 MAPK, serotonin uptake, serotonin, neuroinflammation, interleukin-1 receptor antagonist, SB203580, synaptosomes, midbrain, striatum
- MeSH terms
- Analysis of Variance, Animals, Cell Line, Corpus Striatum, Dose-Response Relationship, Drug, Drug Interactions, Enzyme Activation, Enzyme Inhibitors, Interleukin-1, Mesencephalon, Neurons, Raphe Nuclei, Serotonin, Synaptosomes, Tumor Necrosis Factor-alpha, p38 Mitogen-Activated Protein Kinases, Serotonin Plasma Membrane Transport Proteins, Mice, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review